美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Veraxa Biotech Holding AG

9.46

-11.8000-55.50%

盘前：7.78-1.6756-17.71%05:28 EDT

成交量：56.29万

成交额：600.50万

市值：15.51亿

市盈率：44.16

高：21.57

开：21.57

低：7.82

收：21.26

52周最高：27.36

52周最低：7.82

股本：1.64亿

流通股本：1.58亿

量比：14.38

换手率：0.36%

股息：- -

股息率：- -

每股收益(TTM):0.2142

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Veraxa Biotech Holding AG

交易所：

NASDAQ

成立时间：

2021

员工人数：

- -

公司地址：

Im Neuenheimer Feld 584,Heidelberg,Baden-Württemberg,Germany

官网：

http://www.veraxa.com

邮编：

69120

电话：

49 6221 3521330

传真：

- -

简介：

Veraxa Biotech AG是一家根据瑞士法律成立的股份有限公司。该公司是一家专注于肿瘤治疗的生物技术公司，总部位于瑞士苏黎世，致力于推进新型抗体药物平台在癌症治疗领域的研发。公司的技术源于欧洲分子生物学实验室的科学发现。Veraxa Biotech AG的专有平台技术旨在开发新一代靶向抗体癌症疗法，从而加速下一代癌症治疗方案的研发，并有望通过提高安全性和有效性，拓宽目前实体瘤标准疗法的治疗窗口。

董事

名称

职位

Adeel Rouf

President, Chief Executive Officer and Director

Warren Hosseinion

Chairman of the Board and Director

Jonathan Intrater

Independent Director

Oded Levy

Independent Director

股东

名称

职位

Adeel Rouf

President, Chief Executive Officer and Director

Alex Rogers

Chief Financial Officer

Warren Hosseinion Jr.

Vice President, Mergers and Acquisitions

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/VRXA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":9.46,"timestamp":1781640000000,"preClose":21.26,"halted":0,"volume":562873,"hourTrading":{"tag":"盘前","latestPrice":7.7844,"preClose":9.46,"latestTime":"05:28 EDT","volume":2011,"amount":16699.378187,"timestamp":1781688519692,"change":-1.6756,"changeRate":-0.177125,"amplitude":0.096195},"delay":0,"changeRate":-0.555032925682032,"floatShares":158000000,"shares":164000000,"eps":0.2142,"marketStatus":"盘前交易","change":-11.8,"latestTime":"06-17 05:29:30 EDT","open":21.57,"high":21.57,"low":7.82,"amount":6005034.241166,"amplitude":0.646754,"askPrice":8.79,"askSize":100,"bidPrice":7.75,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.2142,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781703000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":9.46,"preHourTrading":{"tag":"盘前","latestPrice":7.7844,"preClose":9.46,"latestTime":"05:28 EDT","volume":2011,"amount":16699.378187,"timestamp":1781688519692,"change":-1.6756,"changeRate":-0.177125,"amplitude":0.096195},"postHourTrading":{"tag":"盘后","latestPrice":8.5,"preClose":9.46,"latestTime":"19:59 EDT","volume":18898,"amount":165176.4188,"timestamp":1781654369215,"change":-0.96,"changeRate":-0.10148,"amplitude":0.27907},"volumeRatio":14.376162962228134},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":158000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":14.376162962228134,"shares":164000000,"dividePrice":0,"high":21.57,"amplitude":0.646754,"preClose":21.26,"low":7.82,"week52Low":7.82,"pbRate":"--","week52High":27.36,"institutionHeld":0,"latestPrice":9.46,"committee":0.333333,"eps":0.2142,"divideRate":0,"volume":562873,"delay":0,"ttmEps":0.2142,"open":21.57,"prevYearClose":18.65,"prevWeekClose":20,"prevMonthClose":18.65,"prevQuarterClose":18.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":699307581,"yearFounded":2021,"address":"Im Neuenheimer Feld 584,Heidelberg,Baden-Württemberg,Germany","zipCode":"69120","officePhone":"49 6221 3521330"},"stockCompanyDetail":{"websiteUrl":"http://www.veraxa.com","stockEarnings":[{"period":"1week","weight":-0.4928},{"period":"ytd","weight":-0.4928}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1344},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.245},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Veraxa Biotech AG是一家根据瑞士法律成立的股份有限公司。该公司是一家专注于肿瘤治疗的生物技术公司，总部位于瑞士苏黎世，致力于推进新型抗体药物平台在癌症治疗领域的研发。公司的技术源于欧洲分子生物学实验室的科学发现。Veraxa Biotech AG的专有平台技术旨在开发新一代靶向抗体癌症疗法，从而加速下一代癌症治疗方案的研发，并有望通过提高安全性和有效性，拓宽目前实体瘤标准疗法的治疗窗口。","exchange":"NASDAQ","name":"Veraxa Biotech Holding AG","nameEN":"Veraxa Biotech Holding AG"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":{"directors":[{"name":"Adeel Rouf","position":"President, Chief Executive Officer and Director"},{"name":"Warren Hosseinion","position":"Chairman of the Board and Director"},{"name":"Jonathan Intrater","position":"Independent Director"},{"name":"Oded Levy","position":"Independent Director"}],"executives":[{"name":"Adeel Rouf","position":"President, Chief Executive Officer and Director"},{"name":"Alex Rogers","position":"Chief Financial Officer"},{"name":"Warren Hosseinion Jr.","position":"Vice President, Mergers and Acquisitions"}]}}}